As of December 31, 2016, Hadasit Bio-Holdings Ltd has 11.04M shares outstanding.
| Shares Outstanding | 11.04M |
These figures are as of December 31, 2016.
| PB Ratio | -0.02 |
| P/TBV Ratio | 0.05 |
| P/FCF Ratio | -0.20 |
| P/OCF Ratio | -0.20 |
As of December 31, 2016, Hadasit Bio-Holdings Ltd maintains a current ratio of 10.84, meaning it holds 10.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.82, indicating elevated leverage, while an interest coverage ratio of -18.70 demonstrates limited ability to service its debt obligations.
| Current Ratio | 10.84 |
| Quick Ratio | 10.57 |
| Debt / Equity | 2.82 |
| Debt / EBITDA | -0.11 |
| Interest Coverage | -18.70 |
These figures cover the twelve months ended December 31, 2016. Return on assets (ROA) is negative at -2.37, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -2.37 |
As of the close on January 14, 2026, Hadasit Bio-Holdings Ltd's stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 0.12, while the 200-day moving average is 0.13.
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 0.13 |
These figures cover the twelve months ended December 31, 2016. Free cash flow yield is negative at -495.57: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -463.09, meaning Hadasit Bio-Holdings Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -463.09 |
| FCF Yield | -495.57 |
Hadasit Bio-Holdings Ltd's most recent stock split took place on December 20, 2017 with a 1000:1039 split ratio.
| Last Split Date | 12/20/2017 |
| Split Ratio | 1000:1039 |
As of December 31, 2016, Hadasit Bio-Holdings Ltd has an Altman Z-Score of -2.51, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -2.51 |
Already premium?